08/10/2026
LEN won’t sell itself!
HE²RO researcher Refiloe Motaung shares six lessons from our research on oral PrEP uptake that could help make the LEN rollout work better.
Read more: https://bhekisisa.org/opinion/2026-10-07-len-wont-sell-itself-6-lessons-from-hiv-prevention-pills/
South Africa has a twice-yearly HIV prevention jab that’s almost 100% effective. But experience with HIV prevention pills shows that making medicine free isn’t enough to get people to use it. Here are five lessons for making sure LEN reaches the people who need it.